Cite

HARVARD Citation

    Manousaridis, K. et al. (2015). Two Week, OCT-Based follow-up as Guidance for Retreatment with Ranibizumab for CNV Apparently Refractory to Therapy. European journal of ophthalmology. 25 (3), pp. 235-240. [Online]. 
  
Back to record